AbbVie Brings Humira to TrumpRx with Significant Price Reductions In a major shift for pharmaceutical pricing in the U.S., AbbVie has integrated its blockbuster drug Humira into the government’s direct-to-consumer …
Biosimilars
-
-
The Rising Cost of Weight Management and Specialty Drugs: Impact on Private Health Plans Private drug plans are facing a significant financial shift as the cost of weight management medications …
-
China Approves First Commercially Available Brain-Computer Interface China has taken a significant step forward in neurotechnology, granting commercial approval for the country’s first brain-computer interface (BCI) device. Developed by Shanghai-based …
-
Novo Nordisk’s semaglutide Shows Promise in Slowing Cognitive Decline in Alzheimer’s Trial Table of Contents Novo Nordisk’s semaglutide Shows Promise in Slowing Cognitive Decline in Alzheimer’s Trial Trial Details and …
-
FDA Proposal Aims to accelerate Biosimilar Approvals, lowering Drug Costs Primary Topic: Biosimilar drug approvals and their impact on drug pricing. Primary Keyword: Biosimilar approvals Secondary Keywords: biologic drugs, FDA, …